Personalized medicine for lung cancer: new challenges for pathology
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Personalized medicine for lung cancer: new challenges for pathology
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 60, Issue 4, Pages 531-546
Publisher
Wiley
Online
2011-09-15
DOI
10.1111/j.1365-2559.2011.03854.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) according to the presence of the EGFR T790M mutation and BRCA1 mRNA expression levels in pretreatment biopsies.
- (2017) R. Rosell et al. JOURNAL OF CLINICAL ONCOLOGY
- Thymidylate synthetase (TS) immunohistochemistry (IHC): Feasibility in a routine clinical setting for patients receiving treatment with pemetrexed for advanced nonsquamous NSCLC.
- (2017) K. M. Kerr et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer
- (2010) Luis G Paz-Ares et al. BMC CANCER
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Accurate Classification of Non-Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach
- (2010) J. A. Bishop et al. CLINICAL CANCER RESEARCH
- Optimization of genetics to create therapies for metastatic (stage IV) non-small-cell lung cancer
- (2010) Rafael Rosell et al. EXPERT OPINION ON PHARMACOTHERAPY
- Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
- (2010) Giorgio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors
- (2010) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Somatic Mutations of the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitor Response to TKIs in Non-small Cell Lung Cancer: An Analytical Database
- (2010) Samuel Murray et al. Journal of Thoracic Oncology
- Tissue Heterogeneity of EGFR Mutation in Lung Adenocarcinoma
- (2010) Akira Sakurada et al. Journal of Thoracic Oncology
- The Insulin-Like Growth Factor Pathway in Lung Cancer
- (2010) Rafal Dziadziuszko et al. Journal of Thoracic Oncology
- The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer: A Literature Review
- (2010) Fred R. Hirsch et al. Journal of Thoracic Oncology
- Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer
- (2010) Sarah Park et al. Journal of Thoracic Oncology
- EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
- (2010) Kenichi Suda et al. Journal of Thoracic Oncology
- Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer
- (2010) Ana Belén Custodio et al. Journal of Thoracic Oncology
- Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
- (2010) Robert Pirker et al. Journal of Thoracic Oncology
- Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
- (2010) Peh Sun Loo et al. Journal of Thoracic Oncology
- Quantitative Analysis of Tumor in Bronchial Biopsy Specimens
- (2010) Caroline L. Coghlin et al. Journal of Thoracic Oncology
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung
- (2010) Esther Conde et al. PLoS One
- Prospects for molecular staging of non-small-cell lung cancer from genomic alterations
- (2010) Sandra C Tomaszek et al. Expert Review of Respiratory Medicine
- EGFRand K-rasMutations Along the Spectrum of Pulmonary Epithelial Tumors of the Lung and Elaboration of a Combined Clinicopathologic and Molecular Scoring System to Predict Clinical Responsiveness to EGFR Inhibitors
- (2009) Giuliana Sartori et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases
- (2009) K. Schmid et al. CLINICAL CANCER RESEARCH
- KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
- (2009) K. Takeuchi et al. CLINICAL CANCER RESEARCH
- MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy
- (2009) Preeta Tyagi et al. Clinical Lung Cancer
- Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens
- (2009) Said Khayyata et al. DIAGNOSTIC CYTOPATHOLOGY
- Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer
- (2009) Craig Reynolds et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
- (2009) Danit Lebanony et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
- (2009) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential Expression of Biomarkers in Primary Non-small Cell Lung Cancer and Metastatic Sites
- (2009) Carlos Gomez-Roca et al. Journal of Thoracic Oncology
- Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies
- (2009) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
- (2009) Robert Pirker et al. LANCET
- Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
- (2009) Tudor Ciuleanu et al. LANCET
- Molecular predictive and prognostic markers in non-small-cell lung cancer
- (2009) Linda E Coate et al. LANCET ONCOLOGY
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- (2009) Tetsuya Mitsudomi et al. LANCET ONCOLOGY
- VeriStrat® classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab
- (2009) David P. Carbone et al. LUNG CANCER
- Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung
- (2009) Valentina Monica et al. MODERN PATHOLOGY
- A novel five-antibody immunohistochemical test for subclassification of lung carcinoma
- (2009) Brian Z Ring et al. MODERN PATHOLOGY
- Personalized Medicine and Inhibition ofEGFRSignaling in Lung Cancer
- (2009) Adi F. Gazdar NEW ENGLAND JOURNAL OF MEDICINE
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
- (2009) G. Scagliotti et al. ONCOLOGIST
- Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
- (2009) Rafael Rosell et al. PLoS One
- Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
- (2008) A Kalikaki et al. BRITISH JOURNAL OF CANCER
- Non-solid oncogenes in solid tumors:EML4-ALKfusion genes in lung cancer
- (2008) Hiroyuki Mano CANCER SCIENCE
- Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts
- (2008) K. Takeuchi et al. CLINICAL CANCER RESEARCH
- Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non–Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting
- (2008) David A. Eberhard et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Technical pitfalls potentially affecting diagnoses in immunohistochemistry
- (2008) G Bussolati et al. JOURNAL OF CLINICAL PATHOLOGY
- Molecularly Tailored Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer: A Time for Excitement and Equipoise
- (2008) Christopher G. Azzoli et al. Journal of Thoracic Oncology
- Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-small Cell Lung Cancer
- (2008) Gerold Bepler et al. Journal of Thoracic Oncology
- Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- (2008) Edward S Kim et al. LANCET
- EGFR FISH versus mutation: Different tests, different end-points
- (2008) Federico Cappuzzo LUNG CANCER
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now